Globus Medical Inc (GMED)
51.15
+0.67
(+1.33%)
USD |
NYSE |
May 03, 10:28
Globus Medical Cash from Investing (Quarterly): 320.62M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 320.62M |
| September 30, 2023 | -80.86M |
| June 30, 2023 | 52.22M |
| March 31, 2023 | 10.99M |
| December 31, 2022 | -60.48M |
| September 30, 2022 | -63.11M |
| June 30, 2022 | 27.13M |
| March 31, 2022 | -13.89M |
| December 31, 2021 | -243.80M |
| September 30, 2021 | -6.885M |
| June 30, 2021 | -0.143M |
| March 31, 2021 | -125.11M |
| December 31, 2020 | -119.09M |
| September 30, 2020 | 7.661M |
| June 30, 2020 | -3.299M |
| March 31, 2020 | -2.592M |
| December 31, 2019 | -36.04M |
| September 30, 2019 | -13.67M |
| June 30, 2019 | -36.74M |
| March 31, 2019 | -53.84M |
| December 31, 2018 | -52.62M |
| September 30, 2018 | -28.86M |
| June 30, 2018 | -55.43M |
| March 31, 2018 | -56.11M |
| December 31, 2017 | -17.37M |
| Date | Value |
|---|---|
| September 30, 2017 | -35.15M |
| June 30, 2017 | -47.83M |
| March 31, 2017 | -10.93M |
| December 31, 2016 | -69.59M |
| September 30, 2016 | -46.21M |
| June 30, 2016 | -10.81M |
| March 31, 2016 | -36.12M |
| December 31, 2015 | -37.91M |
| September 30, 2015 | -22.84M |
| June 30, 2015 | -48.52M |
| March 31, 2015 | -43.78M |
| December 31, 2014 | -91.43M |
| September 30, 2014 | -3.774M |
| June 30, 2014 | 16.18M |
| March 31, 2014 | -20.98M |
| December 31, 2013 | -45.91M |
| September 30, 2013 | -28.13M |
| June 30, 2013 | -53.16M |
| March 31, 2013 | -99.96M |
| December 31, 2012 | -7.652M |
| September 30, 2012 | -11.21M |
| June 30, 2012 | -5.536M |
| March 31, 2012 | -6.313M |
| December 31, 2011 | -6.793M |
| September 30, 2011 | -3.645M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-243.80M
Minimum
Dec 2021
320.62M
Maximum
Dec 2023
-20.37M
Average
-13.67M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -408.00M |
| Glaukos Corp | -12.92M |
| PROCEPT BioRobotics Corp | -8.715M |
| Paragon 28 Inc | -4.956M |
| Alphatec Holdings Inc | -28.21M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 104.67M |
| Cash from Financing (Quarterly) | -237.27M |
| Free Cash Flow | 165.22M |
| Free Cash Flow Per Share (Quarterly) | 0.5924 |
| Free Cash Flow to Equity (Quarterly) | 74.12M |
| Free Cash Flow to Firm (Quarterly) | 83.35M |
| Free Cash Flow Yield | 2.83% |